OPAT: proof of concept in a peripheral Belgian hospital after review of the literature
- 31 January 2018
- journal article
- research article
- Published by Taylor & Francis in Acta Clinica Belgica
- Vol. 73 (4) , 257-267
Abstract
Since its introduction in the 1970s in the United States, outpatient parenteral antibiotic/antimicrobial therapy (OPAT) has been adopted internationally for long-term intravenous (IV) treatment of stable infectious diseases. The aim is to provide a safe and successful completion of IV antimicrobial treatment at the ambulatory care center or at home without complications and costs associated with hospitalization. OPAT implementation has been accelerated by progress in vascular access devices, newly available antibiotics, the emphasis on cost-savings, as well as an improved patient comfort and a reduced incidence of health care associated infections with a similar outcome. OPAT utilization is supported by an extensive published experience and guidelines of the British Society of Antimicrobial Chemotherapy and the Infectious Diseases Society of America for adults as well as for children. Despite these recommendations and its widespread adoption, in Belgium OPAT is only fully reimbursed and established for cystic fibrosis patients. Possible explanations for this unpopularity include physician unfamiliarity and a lack of uniform funding arrangements with higher costs for the patient. This article aims to briefly review benefits, risks, indications, financial impact for supporting OPAT in a non-university hospital as standard of care. Our experience with OPAT at the ambulatory care center of our hospital and its subsequent recent introduction in the home setting is discussed.Keywords
This publication has 85 references indexed in Scilit:
- An outcomes analysis of outpatient parenteral antibiotic therapy (OPAT) in a large Asian cohortInternational Journal of Antimicrobial Agents, 2013
- Characteristics and Outcomes of Outpatient Parenteral Antimicrobial Therapy at an Academic Children’s HospitalThe Pediatric Infectious Disease Journal, 2013
- Risk factors for failure of outpatient parenteral antibiotic therapy (OPAT) in infective endocarditisJournal of Antimicrobial Chemotherapy, 2013
- Management of suspected Lyme borreliosis: experience from an outpatient parenteral antibiotic therapy serviceQJM: An International Journal of Medicine, 2012
- Outpatient parenteral antimicrobial therapy‐treated bone and joint infections in a tropical settingInternal Medicine Journal, 2011
- Home intravenous antibiotics in a tertiary care hospital in Saudi ArabiaAnnals of Saudi Medicine, 2011
- Long-term stability of temocillin in elastomeric pumps for outpatient antibiotic therapy in cystic fibrosis patientsJournal of Antimicrobial Chemotherapy, 2010
- Patients with Prosthetic Joint Infection on IV Antibiotics are at High Risk for ReadmissionClinical Orthopaedics and Related Research, 2009
- Community-based outpatient parenteral antimicrobial therapy (CoPAT) for Staphylococcus aureus bacteraemia with or without infective endocarditis: analysis of the randomized trial comparing daptomycin with standard therapyJournal of Antimicrobial Chemotherapy, 2009
- Outpatient Parenteral Antimicrobial Therapy for Central Nervous System InfectionsClinical Infectious Diseases, 1999